Assam police seize 50,000 YABA tablets in Silchar, one arrested

Based on secret inputs, Cachar police carried out an anti-narcotics operation in Silchar and held one person with 50,000 YABA tablets, which were being transported from a neighbouring State.

On the otherhand, Special Task Force, Assam conducted an operation and recovered 29,000 tablets at Katahbari in Guwahati.

Two peddlers were arrested in the incident.

Earlier on November 22, the Balajan unit under Dhubri Police, led by Sub-Inspector Purushottam Singh, successfully intercepted a vehicle in Balajan area under Dhubri district as part of a major crackdown on illegal drug trafficking on November 21 and seized huge quantities of contraband drugs.

Also Read: Assam: Eight boxes of heroin seized in Dhubri, three drug peddlers arrested

In response to a tip, the Balajan police unit carried out a Naka checking on Tuesday night in the Baushmari area of Balajan under Dhubri police. They tracked down one vehicle and found two men and a woman inside, along with a significant amount of drugs in their possession.

The operation culminated in the arrest of Biswajit Ali, Harshjit Sheikh and Asma Khatun hailing from Bidyapur village of Bongaigaon district. The seized items included a cache of 100 grams of heroin in 8 soap boxes along with a vehicle bearing registration AS-26F-6664.

Related Posts

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Obesity drug market to gain as Indians pop the pill and Chinese bring more

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March